Roche has said it plans to UK price its latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis - aiming to undercut some established rivals. Approved in Europe earlier ...

The new head of Novartis UK thinks the country has gone backwards in terms of access to medicines, and says his company is moving towards 'payments for outcomes'. Haseeb Ahmad is the new managing ...

Dr Parker said that the British chemistry community is resting its hopes on the current reshaping of the UK pharmaceuticals industry which has been developing a different profile since 2011 when ...

Novartis NVS announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population. The ...

Philip Morris International has agreed to sell its Vectura asthma inhaler maker for only a third of what it paid, after PMI’s ...

NVS' breast cancer drug Kisqali reduces the risk of disease recurrence by 28.5% in a broad population of patients suffering ...

On the client side, there were three pharma companies at the top of the leader board. Novartis (including Novartis and ...

Investing.com -- Shares of Novartis (LON:0QLR) (SIX:NOVN) were down on Wednesday following a downgrade by BofA Securities, which downgraded the Swiss pharmaceutical giant to "neutral" from "buy." At 4 ...

Iberdrola O: 8; L: 8; I: 8; Total: 24 In November 2023, the energy group’s legal team launched a pro-bono programme to ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.